Evidence map›Paper›PMID 20447321›Full record

ArticleCritical care (London, England)2010

Inhaled activated protein C: a new therapy for the prevention of ventilator-induced lung injury?

Edward Abraham

Open access · goldAbstract readComment
In one paragraph

Article in Critical care (London, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Edward AbrahamDepartment of Medicine, University of Alabama at Birmingham School of Medicine, 420 Boshell Building, Birmingham, AL 35294, USA. eabraham@uab.edu
University of Alabama at Birmingham · US

Funding

Urokinase, Neutrophil Activation and Acute Lung Injury.R01HL076206 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI LIU, GANG · 2005 to 2013
$2.8M
HMGB1 and neutrophil efferocytosis.R01GM087748 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZMIJEWSKI, JAROSLAW WALDEMAR · 2009 to 2012
$1.2M
NHLBI NIH HHS HL76206NIGMS NIH HHS GM87748
6 · The paper itself

Abstract

Systemic administration of activated protein C (APC) has been shown to reduce pulmonary inflammation in preclinical models of acute lung injury. However, there is only limited information concerning the effects of inhaled APC in modulating the severity of pulmonary inflammation. In a study reported in this issue of Critical Care, Maniatis and colleagues show that pretreatment of mice with inhaled APC is protective against ventilator-induced lung injury. While the mechanisms responsible for this effect require additional elucidation, inhaled APC appears to be a potentially useful intervention in diminishing the severity of ventilator-induced lung injury and other forms of acute lung injury.

Indexed as

Administration, InhalationAnimalsCritical IllnessMiceProtein CVentilator-Induced Lung InjuryProtein C

Identifiers

PMID20447321
PMCPMC2887193
OpenAlexW2077709763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.